Golden Sun Technology Group Ltd. filed an initial ownership report for its Chief Technology Officer, Wang Lizhen. This Form 3 does not list any share transactions or derivative exercises, and the transaction summary shows no buying, selling, gifts, or other disposals reported at this time.
Golden Sun Technology Group Ltd. director Xu Liming filed an initial ownership report showing indirect holdings of 65,000 Class A ordinary shares. The shares are held through Ever Loyal Industrial Limited, where Xu Liming is the sole shareholder, and the filing does not record any new buy or sell transaction.
Golden Sun Technology Group Ltd. director Yu Zhenghua filed an initial Form 3, which is the required statement of beneficial ownership for new insiders. The filing lists Yu’s status as a director of GSUN but shows no reported transactions or derivative positions at this time.
Golden Sun Technology Group Ltd. executive Ye Duo, the company’s Chief Operating Officer, has filed an initial statement of beneficial ownership as a reporting insider. The Form 3 does not report any share purchase, sale, or other transaction activity; it simply establishes insider reporting status.
Golden Sun Technology Group Ltd. filed an initial insider ownership report for Sun Yu. The filing identifies Sun Yu as an officer of the company, serving as Chief Financial Officer. This Form 3 does not list any insider buy or sell transactions; it simply establishes his reporting status as a company insider.
Golden Sun Technology Group Ltd. director Hao Yidong filed an initial ownership report on Form 3. This filing establishes his status as a director and provides a baseline disclosure of his equity position in the company, without reporting any recent share purchases, sales, or other transactions.
Golden Sun Technology Group Limited, a Cayman holding company with operations in China, reports a major shift from education into e-commerce marketing services. More than 90% of revenue now comes from data‑driven promotion and advertising support on Chinese short‑video platforms, while tutorial services are maintained only on a limited basis.
For the fiscal year ended September 30, 2025, revenue from continuing operations rose to approximately $35.5 million, up about $29.4 million or 483%, mainly from e‑commerce expansion. Despite this growth, the company recorded a net loss of about $5.2 million, 32% higher than the prior year, and its auditor expressed substantial doubt about its ability to continue as a going concern.
As of September 30, 2025, Golden Sun reported an accumulated deficit of $23.6 million, cash of roughly $0.8 million, current assets of about $12.7 million and current liabilities of about $10.6 million. The company implemented a one‑for‑ten share consolidation and, as of that date, had 8,325,870 Class A and 403,000 Class B ordinary shares outstanding. It also changed its name to reflect its new technology and e‑commerce strategy, while highlighting extensive regulatory, licensing, data‑security, tax and PRC policy risks, including exposure to evolving rules on private education, e‑commerce compliance and U.S. oversight under the HFCA Act.
Golden Sun Technology Group Limited has changed its corporate name from “Golden Sun Health Technology Group Limited” to “Golden Sun Technology Group Limited.” The company expects its Class A ordinary shares to begin trading on the Nasdaq Capital Market under the new name on February 5, 2026, while its CUSIP number will stay the same.
The company explains that the new name reflects its updated business strategy and future development plans, including its shift since November 2023 from a primary focus on tutorial services toward data analytics–driven e-commerce marketing and social media promotion services for small and medium-sized businesses in China.
The filing presents the matters submitted for shareholder approval at Golden Sun Technology Group Limited's upcoming meeting. Shareholders are asked to re-elect seven directors and ratify the re-appointment of AssentSure PAC as the company’s independent registered public accounting firm. Two related special resolutions seek to change the company’s English and dual foreign names to remove the word "Health" and to adopt amended constitutional documents to reflect that name change. Another special resolution would implement a Class B variation subject to Class A and B consent. The company also proposes a sizable increase in authorized share capital from US$50,000 to US$1,000,000 and related amendments to the memorandum, plus an ordinary resolution to allow adjournment of the AGM if further proxy solicitation is needed.
Golden Sun Health Technology Group Limited reported a change in its chief operating officer role. On September 18, 2025, Ms. Xiaoyi Wang resigned as COO for personal reasons, and the company stated her departure did not involve any dispute with management or the board. The board appointed Mr. Duo Ye as the new COO, effective the same day.
Mr. Ye brings more than a decade of senior management experience across financial services, asset management, cultural media, and cross-border e-commerce. On September 24, 2025, the company entered into a three-year employment agreement with him, running from September 18, 2025 to September 17, 2028, with automatic renewal unless either party gives two months’ notice. He will receive a monthly salary of $3,233 plus standard benefits, and the agreement allows termination for cause and includes customary confidentiality and non-disclosure covenants. The company states there are no family relationships or related-party transactions involving Mr. Ye.